KPV

KPV is the C-terminal tripeptide (lysine-proline-valine) of alpha-melanocyte-stimulating hormone. The research interest is that it appears to retain anti-inflammatory signalling properties of the parent hormone without its pigmentary activity, which makes it a useful tool compound for isolating one function from another.

Lines of investigation in the literature

• NF-κB pathway signalling. Cell-culture work examining suppression of inflammatory transcription.
• Experimental colitis models. Mouse studies, including work on oral and targeted delivery to intestinal tissue.
• Cytokine expression. Studies measuring interleukin and TNF-alpha responses.
• Peptide transporter uptake. Work on how the tripeptide enters cells, relevant to formulation research.

What the literature does not establish

The body of work is modest in size and concentrated in gastrointestinal inflammation models. There are no human trials establishing effect, and the delivery questions that dominate the laboratory literature are unresolved.